申请人:Valorisation-Recherche, Limited Partnership
公开号:US08993515B2
公开(公告)日:2015-03-31
Novel peptidomimetics comprising N-amino cyclic urea residues are disclosed. Use of such peptidomimetics for modulating the activity of CD36 or IL-1 receptor in a cell, and for treating CD36- or IL-1-related disease, disorder or condition is also described.
本文披露了包含N-氨基环脲残基的新型肽类似物。还描述了利用这种肽类似物来调节细胞中CD36或IL-1受体的活性,并用于治疗与CD36或IL-1相关的疾病、紊乱或状况。